DM 232

Known as: DM-232, unifiram 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
This paper is a review of the work of my former academic group of research in the past 15 years, in the field of cognition… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
A series of amides, structurally related to DM232 (unifiram) and DM235 (sunifiram), characterized by a 1,2,3,4-tetrahydropyrazino… (More)
Is this relevant?
Review
2006
Review
2006
DM232 (unifiram) and DM235 (sunifiram) are potent cognition-enhancers, which are four order of magnitude more potent than… (More)
Is this relevant?
2005
2005
The enantiomers of the potent cognition-enhancer DM232 ((1), unifiram) and of its isopropylsulfonyl analog (2), which is endowed… (More)
Is this relevant?
2004
2004
Structure-activity relationships on two novel potent cognition enhancing drugs, unifiram (DM232, 1) and sunifiram (DM235, 2), are… (More)
Is this relevant?
2003
2003
DM 232 and DM 235 are novel antiamnesic compounds structurally related to ampakines. The involvement of AMPA receptors in the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 5
  • figure 3
Is this relevant?